Ayaka Mizumoto Selected Research

Afatinib

1/2022

HER2 G776S mutation promotes oncogenic potential in colorectal cancer cells when accompanied by loss of APC function.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ayaka Mizumoto Research Topics

Disease

4	Neoplasms (Cancer) 01/2022 - 09/2017
2	Carcinogenesis 01/2020 - 09/2017
2	Esophageal Squamous Cell Carcinoma 01/2020 - 08/2019
1	Sarcoma (Soft Tissue Sarcoma) 10/2021
1	Fanconi Anemia (Fanconi's Anemia) 09/2017
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2017

Drug/Important Bio-Agent (IBA)

2	AcetaldehydeIBA 01/2020 - 09/2017
2	CarcinogensIBA 01/2020 - 09/2017
1	AfatinibIBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	Dronabinol (THC)FDA LinkGeneric 08/2019
1	CurcuminIBA 08/2019
1	DNA AdductsIBA 09/2017

Therapy/Procedure

1	Precision Medicine 10/2021
1	Radiotherapy 01/2020
1	Therapeutics 08/2019